In this study, the expression of p53 (wild-type and mutated form) and bcl-2
in ductal carcinoma im situ (DCIS) and infiltrating ductal carcinoma (IDC)
of the breast was evaluated by immunohistochemistry and PCR-SSCP and corre
lated with cellular kinetic parameters, i.e., mitotic index (MI) and apopto
tic index (AI). The results showed a significant inverse correlation betwee
n p53 and bcl-2 expression in all cases of DCIS and IDC. In the DCIS group,
two subgroups with different kinetic characteristics were identified. The
first group was characterized by p53 positivity, bcl-2 negativity and high
values of MI and AI; the other group was characterized by p53 negativity, b
cl-2 positivity and low values of MI and AI. Conversely, in IDC some cases
were p53 negative, bcl-2 positive and with high values of AI and MI, other
cases were p53 positive, bcl-2 negative and with low AI and MI. Molecular b
iological analysis showed that p53 was wild-type in DCIS, while it was in t
he mutated form in IDC. These results suggest that in IDC mutated p53 contr
ibutes to a change in cellular kinetics and the selection of genetically ab
errant cells, thereby favouring neoplastic progression. The coexistence of
bcl-2 positivity and high AI could be explained by the presence of 'pathway
s' of apoptosis that work independently of bcl-2.